Fig. 2

Levels of iSNVs are higher in immunosuppressed and hospitalized patients. A 2–50% frequency iSNVs in patients of different immunity status. B 50–95% frequency iSNVs in patients of different immunity status. C 2–50% frequency iSNVs in patients of different status of immunity and hospitalization. D 50–95% frequency iSNVs in patients of different status of immunity and hospitalization. The horizontal lines in the box plot represent for 25%, 50% and 75% data percentile. The mean value of each group is shown in black hollow circle. Statistics are performed using the Wilcoxon test, with the p-value significance shown in each comparison. I/H, immunosuppressed and hospitalized; I/NH, immunosuppressed and not hospitalized; NI/H, not immunosuppressed and hospitalized; NI/NH, not immunosuppressed and not hospitalized